Compare BIPC & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIPC | MMSI |
|---|---|---|
| Founded | 2019 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.1B |
| IPO Year | 2019 | 1996 |
| Metric | BIPC | MMSI |
|---|---|---|
| Price | $38.95 | $70.84 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $45.00 | ★ $98.88 |
| AVG Volume (30 Days) | ★ 885.7K | 803.4K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.13% | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | $7.85 | $8.85 |
| Revenue Next Year | $5.94 | $5.88 |
| P/E Ratio | ★ N/A | $104.47 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $34.18 | $59.74 |
| 52 Week High | $51.72 | $96.74 |
| Indicator | BIPC | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 62.78 |
| Support Level | $37.42 | $66.19 |
| Resistance Level | $42.84 | $71.68 |
| Average True Range (ATR) | 1.00 | 2.12 |
| MACD | -0.10 | 0.32 |
| Stochastic Oscillator | 42.82 | 79.45 |
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom, United States, France, Switzerland, Singapore, China, Denmark, Hong Kong, Germany and Others.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.